Tracey Henry
Internal Medicine · Atlanta, GANPI 1710279955
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $304,593 of the $304,704 with a category attached, or 100.0%. Pacira Pharmaceuticals Incorporated accounts for 100.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $208,210 and has fallen 100.0% since, to $41 in 2025. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $30,470 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$305K
- Johnson & Johnson$45
- Inspire Medical Systems, Inc.$41
- Vertex$25
What the payments were for
- Food & beverage$1110%
- Ownership interest$304,593100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $304,593 |
| Johnson & Johnson | 3 | $45 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Vertex | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$208,210
- IOVERA SYSTEM$96,383
How this compares
$304,704 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 31 | $40,604 |
| OzempicSemaglutide | 17 | $34,331 |
| JardianceEmpagliflozin | 20 | $23,327 |
| JanuviaSitagliptin Phosphate | 14 | $20,319 |
| XareltoRivaroxaban | 12 | $9,644 |
| TrulicityDulaglutide | 11 | $9,010 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 19 | $1,360 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,082 |
| Atorvastatin Calcium | 119 | $989 |
| Ventolin HfaAlbuterol Sulfate | 12 | $778 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 22 | $662 |
| Diclofenac Sodium | 21 | $619 |
| Amlodipine Besylate | 101 | $597 |
| Metoprolol Succinate | 24 | $505 |
| Rosuvastatin Calcium | 46 | $492 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $45 | $9,64412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Atlanta
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
- Tanna LimAtlanta$88K
- Sally IwamotoAtlanta$60K
- Antoine TrammellAtlanta$33K
- Samuel AdamsAtlanta$30K
- Jamal HajjariAtlanta$29K
- Carlos SaldanaAtlanta$25K
- Michael HicksonAtlanta$22K
- Robert KaufmannAtlanta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.